Levosimendan appeared to increase in-hospital survival rates, although no long-term survival benefit was reported, among patients with comorbid heart failure and connective tissue disease–associated ...

AMELIA ISLAND—Thrombolex, Inc., a medical device company focused on the design, development and manufacture of innovative endovascular therapies for the treatment of arterial and venous thromboembolic ...

In a recent study published in Nature Cardiovascular Research, researchers modeled the right ventricle (RV) to create a robot replicating right ventricular hemodynamics and biomechanics. Study: ...